TRCT
ERNA icon

Tower Research Capital (TRC)’s Eterna Therapeutics ERNA Stock Holding History

Tower Research Capital (TRC)’s Portfolio ERNA Stock Details ERNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-207
Closed -$5.67K – 5259
2025
Q3 		$5.67K Buy
+207
New +$8.21K ﹤0.01% 4213
2024
Q4 		– Sell
-13
Closed -$5.24K – 5766
2024
Q3 		$5.24K Sell
13
-1
-7% -$640 ﹤0.01% 4304
2024
Q2 		$9.47K Buy
14
+3
+27% +$2.26K ﹤0.01% 4246
2024
Q1 		$9.8K Sell
11
-1
-8% -$690 ﹤0.01% 3788
2023
Q4 		$7.91K Hold
12
– – ﹤0.01% 4560
2023
Q3 		$10K Sell
12
-1
-8% -$921 ﹤0.01% 4155
2023
Q2 		$11.4K Buy
+13
New +$13.1K ﹤0.01% 3983
2023
Q1 		– Sell
-1
Closed -$1.5K – 5919
2022
Q4 		$0 Sell
1
-4
-80% -$5.64K ﹤0.01% 6001
2022
Q3 		$10K Buy
5
+2
+67% +$6.89K ﹤0.01% 4527
2022
Q2 		$10K Buy
3
+2
+200% +$14.4K ﹤0.01% 4441
2022
Q1 		$19K Buy
+1
New +$19K ﹤0.01% 3573
2021
Q4 		– Hold
0
– – – 4271
2021
Q3 		– Hold
0
– – – 4140
2021
Q2 		– Hold
0
– – – 3927
2021
Q1 		– Hold
0
– – – 4589
2020
Q4 		– Hold
0
– – – 4485
2018
Q4 		– Hold
0
– – – 3941
2018
Q3 		– Hold
0
– – – 3890
2016
Q4 		– Hold
0
– -$7K – 3958
2016
Q3 		– Hold
0
– – – 2317
2016
Q1 		– Hold
0
– -$1K – 4324
2015
Q4 		– Hold
0
– – – 4060

Other funds holding ERNA

Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
SCA
Sippican Capital Advisors Boston, Massachusetts $146M AUM 26.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $49B AUM 17.78% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Tower Research Capital (TRC)'s ERNA Position: Q4 2025 in Review

Tower Research Capital (TRC) sold out of Eterna Therapeutics (ERNA) in Q4 2025, closing a stake of 207 shares — an estimated $5.67K sold.

Tower Research Capital (TRC) first reported a position in ERNA in Q1 2022 and held it in 11 quarters. The position peaked at $19K in Q1 2022. 11 funds tracked by Wall St. Rank hold ERNA as of Q4 2025.

  • Tower Research Capital (TRC) reported no remaining Eterna Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 207 Eterna Therapeutics shares in Q4 2025, an estimated $5.67K.
  • Tower Research Capital (TRC) first reported a position in Eterna Therapeutics in Q1 2022 and held it in 11 quarters.
  • Tower Research Capital (TRC)'s Eterna Therapeutics position peaked at $19K in Q1 2022.
  • 11 funds tracked by Wall St. Rank held Eterna Therapeutics as of Q4 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2025, filed 17 Feb 2026.